Hydrophobic Interaction Chromatography Market Size

  • Report ID: 5000
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Hydrophobic Interaction Chromatography Market Size

Hydrophobic Interaction Chromatography Market size was valued at USD 1.7 billion in 2024 and is set to exceed USD 6.15 billion by 2037, expanding at over 10.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of hydrophobic interaction chromatography is evaluated at USD 1.99 billion.

The market growth is rising due to growing cases of infectious diseases, such as COVID-19, and higher development of vaccines. In nations around the world, more than thirty vaccines have been approved for general or emergency use. Since host cells can contaminate the final vaccine product during the manufacture of the viral vaccine, HIC is employed to remove the host cell protein, ensuring the purity and safety of the final vaccine formulations.

Rising cases of patent expiration are likely to boost hydrophobic interaction chromatography market. When a drug's patent expires, manufacturers may be forced to design their own purifying technique in order to make generic medications. In this regard, HIC can be viewed as a viable purification tool for medication development by manufacturers.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5000
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of hydrophobic interaction chromatography is evaluated at USD 1.99 billion.

The hydrophobic interaction chromatography market size was valued at USD 1.7 billion in 2024 and is set to exceed USD 6.15 billion by 2037, expanding at over 10.4% CAGR during the forecast period i.e., between 2025-2037. Rising development of vaccines and higher investment in biopharma industries will boost the market growth.

North America industry is predicted to dominate majority revenue share of 35% by 2037, impelled by growing cases of cancer and autoimmune diseases in the region.

The major players in the market are Sunresin New Materials Co., Ltd.Bio-Rad Laboratories, Inc.Thermo Fisher ScientificThe General Electric CompanySartorius AGTosoh Bioscience, Inc.Sepax Technologies, Inc.Merck KGaA.JNC CorporationGeno Technology Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample